Citron Research tweeted on July 19 that AbbVie is the next great drug short. $ABBV the next great drug short. TGT price $60 Gottlieb’s comments for biosimilars and the removal of safe harbor is a DIRECT hit on Abbvie’s abuse… Read More
This is from the AMM Dividend Letter released February 28, 2014. If you want to see the latest “Dividend Stock in Focus” as soon as it’s released then join our mailing list here. You’ve probably never heard the story of… Read More
Read the 41st issue of the AMM Dividend Letter AMM Dividend Letter 41: How Brewing Beer is Like Investing and Intuit (INTU)